Business, Health Care, Local News

US Food and Drug Administration approves Opdivo Qvantig™ (nivolumab and hyaluronidase-nvhy) injection, for subcutaneous use in most previously approved adult, solid tumor Opdivo® (nivolumab) indications1,2

Opdivo Qvantig is the first and only subcutaneously administered PD-1 inhibitor1 Given over three- to five-minutes, Opdivo Qvantig demonstrated consistent efficacy and showed a comparable safety profile tointravenous Opdivo in the Phase 3 CheckMate-67T trial1,3     PRINCETON, N.J. — (BUSINESS WIRE)

Business, Cultural Corner, News Now!

New York-Jersey City-White Plains home prices up 5.3% year over year in November, according to First American Data & Analytics monthly Home Price Index report

National house prices hover near historical norms —Steady, single-digit house price growth signals a return to normal following the pandemic-to-post-pandemic roller-coaster ride, says Chief Economist Mark Fleming—     SANTA ANA, Calif. — (BUSINESS WIRE) — First American Data & Analytics, a